CALCIUM CAPITAL

Calcium Capital SAS was established in Paris and received its portfolio management licence from the Autorité des Marchés Financiers on 28 August 2020, under approval number GP-20000026. The firm is incorporated as a simplified joint-stock company with a share capital of €225,000, registered in Paris under RCS number 750 150 914, with its registered office at 31 rue de la Baume, 75008 Paris. From the outset, Calcium Capital was designed as a specialist manager focused exclusively on private equity and alternative investment funds, allowing us to develop deep sector expertise rather than spreading resources across unrelated asset classes. Our investment philosophy is grounded in patient capital: we seek companies with defensible market positions and partner with their management teams over multi-year horizons to build lasting enterprise value. We believe that sustainable returns come from operational improvement and strategic clarity, not from financial engineering alone. Governance is central to everything we do — our shareholder engagement policy, conflicts-of-interest framework, and complaints procedure are all maintained as live documents, reviewed regularly and shared with investors on request. Calcium Capital's team brings together professionals with backgrounds in private equity, corporate finance, and regulatory compliance, ensuring that investment rigour and institutional discipline are present at every stage of the fund management cycle. We operate with a lean structure deliberately, as it allows each team member to maintain direct accountability to investors and portfolio companies alike. The firm is committed to transparency: voting records are included in periodic fund reports, and our policies are available to any investor or prospect who requests them. Calcium Capital continues to grow its investor base among professional and qualified investors in France, the broader EEA, Switzerland, and the United Kingdom, in full compliance with applicable cross-border regulations.